Hologic

GPTKB entity

Statements (55)

Predicate	Object
gptkbp:instance_of	gptkb:Company
gptkbp:acquisition	gptkb:2012 gptkb:2018 gptkb:2020 gptkb:Biotheranostics gptkb:Gen-Probe Focal Therapeutics
gptkbp:awards	multiple industry awards
gptkbp:ceo	gptkb:Steve_Mac_Millan
gptkbp:clinical_trial	conducts clinical trials for new products
gptkbp:community_engagement	engages in community health initiatives
gptkbp:customer_base	serves hospitals and clinics globally
gptkbp:employees	~5,000
gptkbp:focus	women's health
gptkbp:founded	gptkb:1985
gptkbp:founder	gptkb:Eliav_E._Shalev
gptkbp:global_presence	operates in over 100 countries
gptkbp:headcount	~5,000 employees
gptkbp:headquarters	gptkb:Marlborough,_Massachusetts gptkb:Marlborough,_Massachusetts,_USA 250 Campus Drive, Marlborough, MA 01752, USA
https://www.w3.org/2000/01/rdf-schema#label	Hologic
gptkbp:industry	gptkb:Insurance_Company
gptkbp:innovation	focuses on innovative healthcare solutions
gptkbp:market_cap	~$15 billion (2021)
gptkbp:market_segment	surgical diagnostics breast health gynaecological health
gptkbp:partnership	gptkb:National_Breast_Cancer_Foundation gptkb:American_College_of_Radiology gptkb:Breast_Cancer_Research_Foundation
gptkbp:philanthropy	donates to health-related charities supports breast cancer awareness initiatives supports women's health programs
gptkbp:products	diagnostic products surgical products breast health products
gptkbp:regulatory_compliance	products approved by CE Mark products approved by FDA
gptkbp:research_and_development	invests heavily in R& D
gptkbp:revenue	$1.5 billion (2020)
gptkbp:subsidiary	gptkb:Hologic_Canada_Inc. gptkb:Hologic_Australia_Pty_Ltd gptkb:Hologic_UK_Limited
gptkbp:sustainability	committed to sustainable practices
gptkbp:symbol	gptkb:HOLX
gptkbp:technology	molecular diagnostics surgical imaging 3 D mammography biopsy systems menstrual health solutions
gptkbp:website	www.hologic.com
gptkbp:bfsParent	gptkb:National_Park
gptkbp:bfsLayer	3